Synthesis and anticancer activity of (E)-2-benzothiazole hydrazones. 2014

Eric B Lindgren, and Monique A de Brito, and Thatyana R A Vasconcelos, and Manuel O de Moraes, and Raquel C Montenegro, and Julliane D Yoneda, and Kátia Z Leal
Programa de Pós-Graduação em Química, Instituto de Química, Universidade Federal Fluminense, Outeiro de São João Batista s/n°, 24020-141 Niterói, RJ, Brazil.

Benzothiazole hydrazones have been synthesized and evaluated for their in vitro antiproliferative activity against three human cancer cell lines: HL-60 (leukemia), MDAMB-435 (breast) and HCT-8 (colon). The good cytotoxicity for the three cancer cell lines and theoretical profile of compounds 3o and 3p pointed them as promising lead molecules for anticancer drug design.

UI MeSH Term Description Entries
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Eric B Lindgren, and Monique A de Brito, and Thatyana R A Vasconcelos, and Manuel O de Moraes, and Raquel C Montenegro, and Julliane D Yoneda, and Kátia Z Leal
July 2016, Antimicrobial agents and chemotherapy,
Eric B Lindgren, and Monique A de Brito, and Thatyana R A Vasconcelos, and Manuel O de Moraes, and Raquel C Montenegro, and Julliane D Yoneda, and Kátia Z Leal
January 2015, Anti-cancer agents in medicinal chemistry,
Eric B Lindgren, and Monique A de Brito, and Thatyana R A Vasconcelos, and Manuel O de Moraes, and Raquel C Montenegro, and Julliane D Yoneda, and Kátia Z Leal
November 2010, European journal of medicinal chemistry,
Eric B Lindgren, and Monique A de Brito, and Thatyana R A Vasconcelos, and Manuel O de Moraes, and Raquel C Montenegro, and Julliane D Yoneda, and Kátia Z Leal
May 2021, ACS infectious diseases,
Eric B Lindgren, and Monique A de Brito, and Thatyana R A Vasconcelos, and Manuel O de Moraes, and Raquel C Montenegro, and Julliane D Yoneda, and Kátia Z Leal
June 1995, Archiv der Pharmazie,
Eric B Lindgren, and Monique A de Brito, and Thatyana R A Vasconcelos, and Manuel O de Moraes, and Raquel C Montenegro, and Julliane D Yoneda, and Kátia Z Leal
December 2019, Archiv der Pharmazie,
Eric B Lindgren, and Monique A de Brito, and Thatyana R A Vasconcelos, and Manuel O de Moraes, and Raquel C Montenegro, and Julliane D Yoneda, and Kátia Z Leal
May 2018, Molecules (Basel, Switzerland),
Eric B Lindgren, and Monique A de Brito, and Thatyana R A Vasconcelos, and Manuel O de Moraes, and Raquel C Montenegro, and Julliane D Yoneda, and Kátia Z Leal
March 2012, Molecules (Basel, Switzerland),
Eric B Lindgren, and Monique A de Brito, and Thatyana R A Vasconcelos, and Manuel O de Moraes, and Raquel C Montenegro, and Julliane D Yoneda, and Kátia Z Leal
March 2012, Medicinal chemistry (Shariqah (United Arab Emirates)),
Eric B Lindgren, and Monique A de Brito, and Thatyana R A Vasconcelos, and Manuel O de Moraes, and Raquel C Montenegro, and Julliane D Yoneda, and Kátia Z Leal
March 2023, ACS omega,
Copied contents to your clipboard!